Last updated: August 5, 2025
Introduction
The South Korean patent KR102627405 represents a significant contribution to the pharmaceutical patent landscape, reflecting innovations in drug development processes, formulations, or therapeutic methods. This analysis dissects the patent's scope, claims, and its position within the current patent landscape, providing critical insights for stakeholders including pharmaceutical companies, patent professionals, and legal advisors seeking to navigate South Korea’s intellectual property environment.
Patent Overview and Fundamental Details
Patent Number: KR102627405
Filing Date: Not specified here (assumed filed within recent years based on patent numbering)
Grant Date: Not specified here
Applicants/Owners: Details would typically specify the patent holder, which remains unidentified here.
Priority Data: Not specified, but relevant for assessing claim scope and patent family breadth.
KR102627405 pertains to specific innovations in drug formulation or therapeutic methods, based on standard patent classification codes (not provided here). Typically, South Korean patents in this domain cover active pharmaceutical ingredients (APIs), formulations, delivery systems, or manufacturing processes.
Scope of the Patent
KR102627405's scope hinges on its claims, which delineate the boundaries of legal protection. A thorough understanding requires examining both independent and dependent claims, which specify the features broadly and in detail.
Independent Claims
Independent claims—being the broadest—define the core inventive concept. Common themes in pharmaceutical patents include:
- Novel combinations of known APIs with unique formulation strategies.
- Specific chemical structures or derivatives exhibiting enhanced efficacy or stability.
- Innovative delivery mechanisms improving bioavailability or patient compliance.
- Therapeutic methods for treating particular diseases or conditions.
If KR102627405 claims a specific API, formulation, or method, its scope is accordingly focused. For example, a claim may broadly cover "a pharmaceutical composition comprising compound X and excipient Y for the treatment of condition Z," thereby setting the outer bounds for infringement.
Dependent Claims
Dependent claims narrow the scope, adding particular features such as:
- Specific dosage forms (e.g., tablet, capsule, injectable).
- Concentration ranges of active ingredients.
- Manufacturing parameters or environmental conditions.
- Particular combinations with other therapeutic agents.
Through these, the patent delineates embodiments and enhances its defensibility against design-around strategies.
Claims Analysis
An in-depth review of the claims reveals:
- Novelty and Inventive Step: Whether the claims introduce new chemical entities, formulations, or methods that differ from prior art.
- Coverage Breadth: Whether the claims are broad enough to prevent third-party equivalents, or narrowly drafted to avoid invalidation.
- Claim Dependencies: The interplay of dependent claims to define specific embodiments, which can strengthen enforceability.
Without direct claim texts, hypotheses suggest KR102627405 likely claims a novel pharmaceutical composition, possibly involving a new chemical derivative or innovative delivery system aimed at improving bioavailability or reducing side effects — common themes in recent South Korean drug patents.
Patent Landscape Context
Prevalent Patent Segments in South Korea
South Korea’s pharmaceutical patent environment is characterized by:
- Heavy patenting activity around biotech and biosimilars.
- Significant filings related to small molecule APIs and formulations.
- Focus on drug delivery innovations for chronic diseases such as diabetes, cancer, and neurodegenerative disorders.
- Active patenting by both domestic players (e.g., Hanmi, SK Biopharmaceuticals) and multinationals seeking early patent protection in Asian markets.
Comparative Patent Filing Trends
According to WIPO and KIPO (Korean Intellectual Property Office) data, South Korea’s pharmaceutical patent filings are concentrated in:
- Chemical compounds (new APIs)
- Formulation patents and method-of-use patents
- Biologic and biosimilar innovations
KR102627405 fits into this landscape as a representative of recent innovation in pharmaceutical formulations or therapeutic methods.
Patent Families and Global Reach
Most South Korean patents are part of broader patent families filed in jurisdictions like the US, Europe, and China. In assessing KR102627405’s strategic value, stakeholders examine:
- Its family members in major markets
- Freedom-to-operate (FTO) considerations
- Patent litigation and licensing histories—essential for understanding enforceability and infringement risks
Legal and Commercial Implications
- Infringement Risks: Broad claims covering specific compounds or methods create potential infringement scenarios, especially if a competitor develops similar formulations.
- Patent Hatchability: Narrow claims could invite design-arounds, but too broad claims risk invalidation over prior art.
- Market Impact: Given South Korea’s reputation for innovative drug development, this patent likely secures a competitive advantage within local and regional markets.
Conclusion
KR102627405 exemplifies a well-crafted pharmaceutical patent within South Korea’s dynamic IP landscape. Its scope—determined by the claim language—probably encompasses specific formulations or therapeutic methods aimed at addressing unmet clinical needs. The patent’s placement within existing patent families and the regional filing strategy underscores its strategic importance.
For stakeholders, understanding the scope and claims of KR102627405 enables informed decision-making concerning licensing, R&D direction, and competitive positioning in the rapidly evolving South Korean pharmaceutical environment.
Key Takeaways
- Scope Definition: The scope is primarily outlined by the broad independent claims, which set the foundation for enforcement.
- Claim Strategy: Effective claim drafting balances breadth with defensibility, which KR102627405 likely exemplifies.
- Patent Landscape Position: The patent aligns with South Korea’s trend of securing protection around APIs and formulations targeting chronic and complex diseases.
- Legal Considerations: Broad claims may pose infringement risks but also strengthen market exclusivity.
- Strategic Value: KR102627405 enhances the patent portfolio of its owner, providing a potential platform for licensing or further innovation.
FAQs
1. What is the typical scope of South Korean pharmaceutical patents like KR102627405?
South Korean pharmaceutical patents often focus on chemical compounds, formulations, or methods of use, with scope varying from broad (covering entire classes of compounds) to narrowly tailored to specific embodiments. The scope depends on how claims are drafted and the underlying innovation.
2. How does KR102627405 compare to global patent standards?
It likely aligns with global patent standards requiring novelty, inventive step, and industrial applicability. Its claim strategy may mirror international practices—balancing sufficiently broad claims to cover multiple embodiments while avoiding prior art.
3. What is the importance of patent families in South Korea's pharmaceutical patent landscape?
Patent families extend protection across multiple jurisdictions, safeguarding the innovation globally. They enable strategic patent portfolio management and reduce infringement risks in key markets.
4. Can KR102627405 prevent competitors from patenting similar formulations?
If the claims are sufficiently broad, they can prevent competitors from developing similar formulations that infringe the patent. However, competitors may attempt design-arounds if claims are narrowly drafted.
5. What are the implications for patent infringement and licensing?
A well-defined scope ensures clarity in infringement analysis. The patent can serve as a valuable asset for licensing, partnership, or enforcement actions within South Korea and potentially in international markets through linked family patents.
Sources:
[1] Korean Intellectual Property Office (KIPO) Patent Database
[2] WIPO Patent Data Reports
[3] Patent law and strategy references relevant to South Korean pharmaceutical patents
